Search Clinical Trials
608,149 trials
ID
Status
Phase
Title
Sponsor
NCT07891988
Preventing Kidney Injury Using Carbon Dioxide as Contrast Medium in Patients With Peripheral Arterial Disease (PAD) and Chronic Kidney Disease (CKD) Having Arterial InterventionKing's College LondonActive Not RecruitingNot Applicable
NCT07891988Active Not Recruiting
Not Applicable
Preventing Kidney Injury Using Carbon Dioxide as Contrast Medium in Patients Wit...King's College London
NCT07892443
Type 2 Inflammation in Adults With Cystic FibrosisNational Heart, Lung, and Blood Institute (NHLBI)Not Yet Recruiting
NCT07892443Not Yet Recruiting
—
Type 2 Inflammation in Adults With Cystic FibrosisNational Heart, Lung, and...
NCT07891975
Modulatory Effects of Resveratrol Supplement Along With and Without Low Glycemic Index Diet Among Obese Patients With Diabetic NephropathyUniversity of LahoreCompletedNot Applicable
NCT07891975Completed
Not Applicable
Modulatory Effects of Resveratrol Supplement Along With and Without Low Glycemic...University of Lahore
NCT07892885
A Clinical Trial to Evaluate the Efficacy and Safety of Meltz, a Digital Therapeutic Device, for Improving Panic Symptoms in Patients With Panic DisorderAIMNEXTNot Yet RecruitingNot Applicable
NCT07892885Not Yet Recruiting
Not Applicable
A Clinical Trial to Evaluate the Efficacy and Safety of Meltz, a Digital Therape...AIMNEXT
NCT07891559
Trauma Suppression Training for VeteransPalo Alto Veterans Institute for ResearchCompletedNot Applicable
NCT07891559Completed
Not Applicable
Trauma Suppression Training for VeteransPalo Alto Veterans Instit...
NCT07891871
RE-RITE: Real-world Evaluation of Response, Implementation and Toxicity of ElranatamabPfizerNot Yet Recruiting
NCT07891871Not Yet Recruiting
—
RE-RITE: Real-world Evaluation of Response, Implementation and Toxicity of Elran...Pfizer
NCT07892625
A Phase I Study of HS-20093 in Combination With ZG006 With or Without Adebrelimab in Patients With ES-SCLCHansoh BioMedical R&D CompanyNot Yet RecruitingPhase 1
NCT07892625Not Yet Recruiting
Phase 1
A Phase I Study of HS-20093 in Combination With ZG006 With or Without Adebrelima...Hansoh BioMedical R&D Com...
NCT07891923
Less Doses of Daratumumab Are Adequate to Achieve Response in Newly Diagnosed Multiple MyelomaIndian Council of Medical ResearchRecruitingPhase 2
NCT07891923Recruiting
Phase 2
Less Doses of Daratumumab Are Adequate to Achieve Response in Newly Diagnosed Mu...Indian Council of Medical...
NCT07892495
The Clinical Efficacy and Multimodal Imaging Mechanism of the Knot-tying Technique in the Treatment of Chronic Neck PainLi JuntaoNot Yet RecruitingNot Applicable
NCT07892495Not Yet Recruiting
Not Applicable
The Clinical Efficacy and Multimodal Imaging Mechanism of the Knot-tying Techniq...Li Juntao
NCT07893223
Vancomycin Exposure and Biomarker Tracking Using Real-time Monitoring of Interstitial FluidNutromicsNot Yet Recruiting
NCT07893223Not Yet Recruiting
—
Vancomycin Exposure and Biomarker Tracking Using Real-time Monitoring of Interst...Nutromics
NCT07892092
Long-Term Cardiovascular Impact of ArmoLIPID Cholesterol Plus: An In Silico Study Using Digital TwinsAeterna Medical Solutions SLCompleted
NCT07892092Completed
—
Long-Term Cardiovascular Impact of ArmoLIPID Cholesterol Plus: An In Silico Stud...Aeterna Medical Solutions...
NCT07892573
Becotatug Vedotin Plus Anti-PD-1 and S-1 in Patients With EGFR-Positive Advanced Pancreatic Cancer Who Have Failed at Least One Line of Standard TherapyNingbo Medical Center Lihuili HospitalRecruitingNot Applicable
NCT07892573Recruiting
Not Applicable
Becotatug Vedotin Plus Anti-PD-1 and S-1 in Patients With EGFR-Positive Advanced...Ningbo Medical Center Lih...
NCT07891832
Video Laryngeal Mask SaCoVLM Versus LMA Supreme and Ambu AuraGain in ChildrenCharles University, Czech RepublicNot Yet RecruitingNot Applicable
NCT07891832Not Yet Recruiting
Not Applicable
Video Laryngeal Mask SaCoVLM Versus LMA Supreme and Ambu AuraGain in ChildrenCharles University, Czech...
NCT07891650
Personalized Intermittent Theta Burst Stimulation for Cognitive Impairment Related to Cerebral Small Vessel DiseaseMinistry of Science and Technology of the People´s Republic of ChinaNot Yet RecruitingNot Applicable
NCT07891650Not Yet Recruiting
Not Applicable
Personalized Intermittent Theta Burst Stimulation for Cognitive Impairment Relat...Ministry of Science and T...
NCT07891234
Effect of SGLT2 Inhibitor on Metabolic-Dysfunction-Associated Fatty Liver Disease in Patients With Insulin ResistanceAin Shams UniversityNot Yet RecruitingPhase 4
NCT07891234Not Yet Recruiting
Phase 4
Effect of SGLT2 Inhibitor on Metabolic-Dysfunction-Associated Fatty Liver Diseas...Ain Shams University
NCT07892820
Evaluation of Different Grafting Technique of Thin Gingival Phenotype With Delayed Dental ImplantsFuture University in EgyptRecruitingNot Applicable
NCT07892820Recruiting
Not Applicable
Evaluation of Different Grafting Technique of Thin Gingival Phenotype With Delay...Future University in Egyp...
NCT07891195
Effect of a Brief Educational Intervention on Endotracheal Tube Cuff PressureMarmara University Pendik Training and Research HospitalNot Yet RecruitingNot Applicable
NCT07891195Not Yet Recruiting
Not Applicable
Effect of a Brief Educational Intervention on Endotracheal Tube Cuff PressureMarmara University Pendik...
NCT07891845
Comparison of Two Surgical Techniques for Indirect Inguinal Hernia RepairHitit UniversityRecruitingNot Applicable
NCT07891845Recruiting
Not Applicable
Comparison of Two Surgical Techniques for Indirect Inguinal Hernia RepairHitit University
NCT07891949
Plasmonic PhotoThermal Therapy (PPTT) With Glucose-Coated Gold Nanoparticles (TSK-001) in Patients With Nodular Basal Cell Carcinoma (nBCC)Torskal SASNot Yet RecruitingNot Applicable
NCT07891949Not Yet Recruiting
Not Applicable
Plasmonic PhotoThermal Therapy (PPTT) With Glucose-Coated Gold Nanoparticles (TS...Torskal SAS
NCT07892651
MENA/Levant Epidemiological, Registry of Immunological & Clinical Traits (MERIT)Axiom BioregistryNot Yet Recruiting
NCT07892651Not Yet Recruiting
—
MENA/Levant Epidemiological, Registry of Immunological & Clinical Traits (MERIT)Axiom Bioregistry
Result Breakdown
Not yet recruiting12 (60%)
Recruiting4 (20%)
Completed3 (15%)
Active, not recruiting1 (5%)
not_applicable12 (60%)
Not Specified5 (25%)
Phase 11 (5%)
Phase 21 (5%)
Phase 41 (5%)